GlassScriptPhysician profile
Jacey Cartwright
NPI 1609589431
$553.56
in general payments reported to CMS, 2019-2025
11 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $135 · 2024: $101 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $96.12 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $84.91 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $77.75 | 2023-2024 | Aptima |
| Abbvie INC. | $67.57 | 2023-2025 | |
| Millicent US INC | $52.90 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Novo Nordisk INC | $40.11 | 2023 | Saxenda, Wegovy |
| Smith+Nephew, INC. | $35.35 | 2025 | Pico 14 |
| Organon LLC | $33.90 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $28.58 | 2025 | |
| Coopersurgical, INC. | $18.21 | 2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $18.16 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacey Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.